A study to assess impact of molecular response at 3 months, 6 months and 12 months on survival in patients treated with second generation Tyrosine kinase inhibitors
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update:
06 Jan 2021
Price :
$35
*
Note:
-
Adis is an information provider.
-
Final gross price and currency may vary according to local VAT and billing address.
-
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
-
A link to download a PDF version of the trial profile will be included in your email receipt.